First Command Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25K Buy
+4
New +$1.18K ﹤0.01% 1251

Other funds holding LGND

First Command Advisory Services's LGND Position: Q3 2026 in Review

First Command Advisory Services opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 4 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #1251 among its holdings.

434 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • First Command Advisory Services held 4 shares of Ligand Pharmaceuticals worth $1.25K as of Q3 2026.
  • Ligand Pharmaceuticals was a new First Command Advisory Services position in Q3 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of First Command Advisory Services's portfolio in Q3 2026, its #1251 holding.
  • 434 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on First Command Advisory Services's 13F filing for Q3 2026, filed 5 Nov 2026.